Skip to main content
HR 467 117th Congress House Health Cardiovascular and respiratory health Drug therapy Emergency medical services and trauma care Health care costs and insurance Health care coverage and access Immunology and vaccination Infectious and parasitic diseases

Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021

Introduced: January 25, 2021 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 2, 2021
Referred to the Subcommittee on Health.
Jan 25, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 25, 2021
Referred to the Subcommittee on Health.
Jan 25, 2021
Introduced in House
 Plain-English summary Congressional Research Service

Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021

This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.

What's happening now February 2, 2021

Referred to the Subcommittee on Health.

 Committees of jurisdiction 5